AU Stock MarketDetailed Quotes

CPH Creso Pharma Ltd

Watchlist

0.009
0.0000.00%

20min DelayMarket Closed Apr 12 10:00 AET

23.11MMarket Cap-409P/E (Static)

Creso Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 30, 2022

(FY)Dec 30, 2021

(FY)Dec 30, 2020

(FY)Dec 30, 2019

(FY)Dec 30, 2018

(FY)Dec 30, 2017

(FY)Dec 30, 2016

Total revenue

39.73%8.69M

154.04%6.22M

-32.50%2.45M

549.45%3.63M

129.03%558.38K

2,939.12%243.8K

8.02K

Operating revenue

39.73%8.69M

154.04%6.22M

-32.50%2.45M

549.45%3.63M

129.03%558.38K

2,939.12%243.8K

--8.02K

Cost of revenue

26.94%8.4M

4.56%6.62M

321.86%6.33M

324.40%1.5M

-19.22%353.57K

1,233.30%437.7K

32.83K

Gross profit

171.64%287K

89.68%-400.61K

-282.63%-3.88M

937.95%2.13M

205.63%204.82K

-681.66%-193.9K

-24.81K

Operating expense

-30.31%19.48M

166.57%27.95M

-14.75%10.49M

-17.83%12.3M

8.08%14.97M

233.12%13.85M

4.16M

Selling and administrative expenses

-22.49%7.9M

140.01%10.19M

-33.03%4.25M

-41.13%6.34M

48.44%10.77M

175.07%7.25M

--2.64M

-Selling and marketing expense

-71.18%1.68M

492.07%5.84M

41.29%986.18K

-43.32%698K

-32.57%1.23M

666.70%1.83M

--238.23K

-General and administrative expense

42.85%6.21M

33.48%4.35M

-42.23%3.26M

-40.85%5.64M

75.70%9.54M

126.25%5.43M

--2.4M

Research and development costs

----

20.61%344.99K

-0.18%286.03K

-63.67%286.54K

61.28%788.62K

--488.98K

Depreciation amortization depletion

632.29%1.95M

-24.48%266.15K

-12.26%352.43K

937.34%401.67K

483.32%38.72K

403.64%6.64K

--1.32K

-Depreciation and amortization

632.29%1.95M

-24.48%266.15K

-12.26%352.43K

937.34%401.67K

483.32%38.72K

403.64%6.64K

--1.32K

Provision for doubtful accounts

----

--102.15K

----

Other operating expenses

-44.95%9.63M

215.65%17.5M

5.10%5.54M

39.75%5.27M

-34.94%3.77M

463.07%5.8M

--1.03M

Operating profit

32.31%-19.19M

-97.33%-28.35M

-41.21%-14.37M

31.09%-10.17M

-5.13%-14.76M

-235.78%-14.04M

-4.18M

Net non-operating interest income (expenses)

64.37%-608K

81.59%-1.71M

-355.92%-9.27M

-605.44%-2.03M

-392.71%-288.18K

425.43%98.45K

-30.25K

Non-operating interest income

8,399,900.00%84K

-99.68%1

-99.44%317

-60.36%57.09K

46.30%144.04K

1,415.13%98.45K

--6.5K

Non-operating interest expense

-59.45%692K

-81.59%1.71M

343.48%9.27M

383.56%2.09M

--432.22K

----

--36.75K

Other net income (expenses)

-45,728.71%-12.98M

100.40%28.45K

-128.06%-7.14M

-74.68%-3.13M

-58.65%-1.79M

-204.28%-1.13M

-371.41K

Special income (charges)

---12.52M

----

-53.62%-4.67M

-614.12%-3.04M

60.35%-425.83K

-211.60%-1.07M

---344.71K

-Less:Impairment of capital assets

--12.52M

----

53.62%4.67M

614.12%3.04M

-60.35%425.83K

211.60%1.07M

--344.71K

Other non-operating income (expenses)

-1,713.53%-459K

101.15%28.45K

-2,615.38%-2.47M

93.34%-91.01K

-2,340.17%-1.37M

-109.77%-56.03K

---26.71K

Income before tax

-9.15%-32.78M

2.43%-30.03M

-100.65%-30.78M

8.94%-15.34M

-11.74%-16.85M

-228.87%-15.08M

-4.58M

Income tax

Earnings from equity interest net of tax

Net income

-9.16%-32.78M

2.43%-30.03M

-100.65%-30.78M

8.94%-15.34M

-11.74%-16.85M

-228.87%-15.08M

-4.58M

Net income continuous operations

-9.16%-32.78M

2.43%-30.03M

-100.65%-30.78M

8.94%-15.34M

-11.74%-16.85M

-228.87%-15.08M

---4.58M

Noncontrolling interests

-218.34%-285.39K

-89.65K

Net income attributable to the company

-9.16%-32.78M

2.43%-30.03M

-104.46%-30.78M

10.16%-15.05M

-11.14%-16.76M

-228.87%-15.08M

-4.58M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-9.16%-32.78M

2.43%-30.03M

-104.46%-30.78M

10.16%-15.05M

-11.14%-16.76M

-228.87%-15.08M

-4.58M

Diluted earnings per share

17.34%-0.0224

67.35%-0.0271

20.73%-0.083

29.68%-0.1047

17.87%-0.1489

-25.73%-0.1813

-0.1442

Basic earnings per share

17.34%-0.0224

67.35%-0.0271

20.73%-0.083

29.68%-0.1047

17.87%-0.1489

-25.73%-0.1813

-0.1442

Dividend per share

Accounting Standards

US-GAAP

	(FY)Dec 30, 2022	(FY)Dec 30, 2021	(FY)Dec 30, 2020	(FY)Dec 30, 2019	(FY)Dec 30, 2018	(FY)Dec 30, 2017	(FY)Dec 30, 2016
Total revenue	39.73%8.69M	154.04%6.22M	-32.50%2.45M	549.45%3.63M	129.03%558.38K	2,939.12%243.8K	8.02K
Operating revenue	39.73%8.69M	154.04%6.22M	-32.50%2.45M	549.45%3.63M	129.03%558.38K	2,939.12%243.8K	--8.02K
Cost of revenue	26.94%8.4M	4.56%6.62M	321.86%6.33M	324.40%1.5M	-19.22%353.57K	1,233.30%437.7K	32.83K
Gross profit	171.64%287K	89.68%-400.61K	-282.63%-3.88M	937.95%2.13M	205.63%204.82K	-681.66%-193.9K	-24.81K
Operating expense	-30.31%19.48M	166.57%27.95M	-14.75%10.49M	-17.83%12.3M	8.08%14.97M	233.12%13.85M	4.16M
Selling and administrative expenses	-22.49%7.9M	140.01%10.19M	-33.03%4.25M	-41.13%6.34M	48.44%10.77M	175.07%7.25M	--2.64M
-Selling and marketing expense	-71.18%1.68M	492.07%5.84M	41.29%986.18K	-43.32%698K	-32.57%1.23M	666.70%1.83M	--238.23K
-General and administrative expense	42.85%6.21M	33.48%4.35M	-42.23%3.26M	-40.85%5.64M	75.70%9.54M	126.25%5.43M	--2.4M
Research and development costs	----	----	20.61%344.99K	-0.18%286.03K	-63.67%286.54K	61.28%788.62K	--488.98K
Depreciation amortization depletion	632.29%1.95M	-24.48%266.15K	-12.26%352.43K	937.34%401.67K	483.32%38.72K	403.64%6.64K	--1.32K
-Depreciation and amortization	632.29%1.95M	-24.48%266.15K	-12.26%352.43K	937.34%401.67K	483.32%38.72K	403.64%6.64K	--1.32K
Provision for doubtful accounts	----	----	----	----	--102.15K	----	----
Other operating expenses	-44.95%9.63M	215.65%17.5M	5.10%5.54M	39.75%5.27M	-34.94%3.77M	463.07%5.8M	--1.03M
Operating profit	32.31%-19.19M	-97.33%-28.35M	-41.21%-14.37M	31.09%-10.17M	-5.13%-14.76M	-235.78%-14.04M	-4.18M
Net non-operating interest income (expenses)	64.37%-608K	81.59%-1.71M	-355.92%-9.27M	-605.44%-2.03M	-392.71%-288.18K	425.43%98.45K	-30.25K
Non-operating interest income	8,399,900.00%84K	-99.68%1	-99.44%317	-60.36%57.09K	46.30%144.04K	1,415.13%98.45K	--6.5K
Non-operating interest expense	-59.45%692K	-81.59%1.71M	343.48%9.27M	383.56%2.09M	--432.22K	----	--36.75K
Other net income (expenses)	-45,728.71%-12.98M	100.40%28.45K	-128.06%-7.14M	-74.68%-3.13M	-58.65%-1.79M	-204.28%-1.13M	-371.41K
Special income (charges)	---12.52M	----	-53.62%-4.67M	-614.12%-3.04M	60.35%-425.83K	-211.60%-1.07M	---344.71K
-Less:Impairment of capital assets	--12.52M	----	53.62%4.67M	614.12%3.04M	-60.35%425.83K	211.60%1.07M	--344.71K
Other non-operating income (expenses)	-1,713.53%-459K	101.15%28.45K	-2,615.38%-2.47M	93.34%-91.01K	-2,340.17%-1.37M	-109.77%-56.03K	---26.71K
Income before tax	-9.15%-32.78M	2.43%-30.03M	-100.65%-30.78M	8.94%-15.34M	-11.74%-16.85M	-228.87%-15.08M	-4.58M
Income tax	2K	0	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-9.16%-32.78M	2.43%-30.03M	-100.65%-30.78M	8.94%-15.34M	-11.74%-16.85M	-228.87%-15.08M	-4.58M
Net income continuous operations	-9.16%-32.78M	2.43%-30.03M	-100.65%-30.78M	8.94%-15.34M	-11.74%-16.85M	-228.87%-15.08M	---4.58M
Noncontrolling interests				-218.34%-285.39K	-89.65K
Net income attributable to the company	-9.16%-32.78M	2.43%-30.03M	-104.46%-30.78M	10.16%-15.05M	-11.14%-16.76M	-228.87%-15.08M	-4.58M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-9.16%-32.78M	2.43%-30.03M	-104.46%-30.78M	10.16%-15.05M	-11.14%-16.76M	-228.87%-15.08M	-4.58M
Diluted earnings per share	17.34%-0.0224	67.35%-0.0271	20.73%-0.083	29.68%-0.1047	17.87%-0.1489	-25.73%-0.1813	-0.1442
Basic earnings per share	17.34%-0.0224	67.35%-0.0271	20.73%-0.083	29.68%-0.1047	17.87%-0.1489	-25.73%-0.1813	-0.1442
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall